Delta Secretase and BDNF Signalling in Alzheimer's Disease

被引:0
|
作者
Unlu, Buse [1 ]
Ildiz, Sumeyra [1 ]
Ak, Duygu Gezen [1 ]
Dursun, Erdinc [1 ]
机构
[1] Istanbul Univ Cerrahpasa, Inst Neurol Sci, Dept Neurosci, Istanbul, Turkiye
来源
EXPERIMED | 2023年 / 13卷 / 01期
关键词
BDNF; axonal transport; delta secretase; Alzheimer's disease; APP; tau protein; AXONAL-TRANSPORT; TAU; PHOSPHORYLATION; RECEPTORS; CLEAVAGE; LEGUMAIN; BETA;
D O I
10.26650/experimed.1231893
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
As one of the major contributors of the central nervous system, neurons require neurotrophic factors, which are synthesized from neighbouring cells, for several cellular processes, such as neuronal survival, growth, and differentiation. Neurotrophic factors are categorized into the neurotrophin family, the neuropoietic cytokines, and the glial cell-derived neurotrophic factor. The neurotrophin family comprises four growth factors: nerve growth factor (NGF), neurotrophin-3 (NT3), neurotrophin-4 (NT4), and brain-derived neurotrophic factor (BDNF). One of the best-known neurotrophic factors is BDNF. Its importance is based on its central role in neuronal survival. Entry of the BDNF into the neurons occurs via TrkB receptors, and it is transported to the cell body along microtubules in axons. As it is known in the brains of Alzheimer's patients, the axonal transport of BDNF is destructed via the hyperphosphorylated tau. There are several causes for the hyperphosphorylation of tau. Among them, delta secretase (delta-secretase), a lysosomal cysteine protease, cleaves both amyloid precursor protein (APP) and tau. It is supposed to play an essential role in tau hyperphosphorylation, particularly in the aging brain. In this review, we focus on the activity of delta-secretase, how it leads to tau hyperphosphorylation, and how it disrupts the axonal transport of BDNF in Alzheimer's disease.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [21] ALZHEIMER'S DISEASE Selectively tuning γ-secretase
    St George-Hyslop, Peter
    Schmitt-Ulms, Gerold
    NATURE, 2010, 467 (7311) : 36 - 37
  • [22] γ-Secretase:: a complex target for Alzheimer's disease
    Lundkvist, Johan
    Naslund, Jan
    CURRENT OPINION IN PHARMACOLOGY, 2007, 7 (01) : 112 - 118
  • [23] Challenges to the enigma of γ-secretase and to Alzheimer's disease
    Iwatsubo, Takeshi
    Alzheimer: 100 Years and Beyond, 2006, : 261 - 263
  • [24] γ-Secretase Inhibitors for the Treatment of Alzheimer's Disease
    Wu, Wen-Lian
    Zhang, Lili
    DRUG DEVELOPMENT RESEARCH, 2009, 70 (02) : 94 - 100
  • [25] Targeting γ-secretase for familial Alzheimer’s disease
    Michael S. Wolfe
    Medicinal Chemistry Research, 2021, 30 : 1321 - 1327
  • [26] γ-secretase inhibition and modulation for Alzheimer's disease
    Wolfe, Michael S.
    CURRENT ALZHEIMER RESEARCH, 2008, 5 (02) : 158 - 164
  • [27] Inhibition and modulation of γ-secretase for Alzheimer's disease
    Wolfe, Michael S.
    NEUROTHERAPEUTICS, 2008, 5 (03) : 391 - 398
  • [28] β-secretase as a target for the treatment of Alzheimer's disease
    Citron, M
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (03) : 373 - 379
  • [29] Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease
    Zhentao Zhang
    Mingke Song
    Xia Liu
    Seong Su Kang
    Duc M. Duong
    Nicholas T. Seyfried
    Xuebing Cao
    Liming Cheng
    Yi E. Sun
    Shan Ping Yu
    Jianping Jia
    Allan I. Levey
    Keqiang Ye
    Nature Communications, 6
  • [30] Secretase inhibitors as therapeutics for Alzheimer's disease
    Olson, RE
    Thompson, LA
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35, 2000, 35 : 31 - 40